M. Robson

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2

K. Offit, K. Nathanson, S. Domchek, 2009, Breast Cancer Research and Treatment.

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

D. Lake, C. Hudis, L. Norton, 2008, Breast Cancer Research and Treatment.

Prophylactic mastectomy in carriers of BRCA mutations.

K. Offit, D. Schrag, M. Robson, 2001, The New England journal of medicine.

Unique de novo mutation of BRCA2 in a woman with early onset breast cancer

K. Offit, N. Ellis, M. Robson, 2002, Journal of medical genetics.

Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.

J. Barrett, D. Hodgson, E. Harrington, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

S. Cummings, S. Loader, P. Rowley, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

M. Ladanyi, J. Reis-Filho, K. Offit, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk of endometrial carcinoma associated with BRCA mutation.

J. Satagopan, K. Offit, D. Levine, 2001, Gynecologic oncology.

Four-year follow-up of outcomes following risk-reducing salpingo-oophorectomy in BRCA mutation carriers

C. Hudis, K. Offit, J. Boyd, 2005 .

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

C. Hudis, K. Offit, T. Kirchhoff, 2011, Breast Cancer Research and Treatment.

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

C B Begg, W Foulkes, K Offit, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

C. Hudis, K. Offit, M. Gönen, 2011, Breast Cancer Research and Treatment.

Multi-center prospective analysis of risk-reducing salpingo-oophorectomy to prevent BRCA-associated breast and ovarian cancer.

T. Rebbeck, L. Norton, K. Offit, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.